Ancora Advisors LLC Cuts Stock Holdings in Lifevantage Corporation $LFVN

Ancora Advisors LLC trimmed its position in Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 93.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,215 shares of the company's stock after selling 60,715 shares during the period. Ancora Advisors LLC's holdings in Lifevantage were worth $61,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of LFVN. Driehaus Capital Management LLC acquired a new position in shares of Lifevantage during the 1st quarter worth approximately $6,701,000. Capital Management Corp VA boosted its holdings in shares of Lifevantage by 137.2% during the 1st quarter. Capital Management Corp VA now owns 715,503 shares of the company's stock worth $10,432,000 after purchasing an additional 413,918 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Lifevantage by 393,513.8% during the 1st quarter. Russell Investments Group Ltd. now owns 114,148 shares of the company's stock worth $1,664,000 after purchasing an additional 114,119 shares during the last quarter. Trexquant Investment LP acquired a new position in shares of Lifevantage during the 1st quarter worth approximately $1,607,000. Finally, Jane Street Group LLC acquired a new position in shares of Lifevantage during the 4th quarter worth approximately $608,000. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Stock Down 5.3%

NASDAQ LFVN traded down $0.62 on Friday, reaching $11.10. The stock had a trading volume of 142,973 shares, compared to its average volume of 192,886. The firm has a market capitalization of $140.87 million, a price-to-earnings ratio of 15.00 and a beta of 0.39. Lifevantage Corporation has a 12-month low of $9.77 and a 12-month high of $27.38. The stock has a fifty day moving average price of $13.01 and a two-hundred day moving average price of $13.51.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported $0.17 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.17. The company had revenue of $55.11 million for the quarter, compared to analyst estimates of $57.93 million. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.During the same quarter in the previous year, the company earned $0.14 earnings per share. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Monday, September 8th will be given a $0.045 dividend. The ex-dividend date of this dividend is Monday, September 8th. This represents a $0.18 dividend on an annualized basis and a yield of 1.6%. Lifevantage's payout ratio is presently 24.32%.

Insider Buying and Selling

In other Lifevantage news, CFO Carl Aure sold 2,746 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer owned 133,303 shares of the company's stock, valued at $1,784,927.17. The trade was a 2.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael A. Beindorff sold 4,125 shares of the business's stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $11.44, for a total transaction of $47,190.00. Following the completion of the transaction, the director owned 22,858 shares of the company's stock, valued at approximately $261,495.52. This trade represents a 15.29% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 7,071 shares of company stock worth $86,229. 20.65% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut Lifevantage from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 6th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $30.50.

Lifevantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.